Literature DB >> 17900201

Telemedicine for the medicare population: update.

William R Hersh, David H Hickam, Susan M Severance, Tracy L Dana, Kathryn Pyle Krages, Mark Helfand.   

Abstract

CONTEXT: Telemedicine services are increasingly utilized by patients, clinicians, and institutions. Although private and Federal insurers are covering some telemedicine services, the rationale for these coverage decisions is not always evidence-based.
OBJECTIVES: The goal of this report was to assess the peer-reviewed literature for telemedicine services that substitute for face-to-face medical diagnosis and treatment that may apply to the Medicare population. We focused on three distinct areas: store-and-forward, home-based, and office/hospital-based services. We also sought to identify what progress had been made in expanding the evidence base since the publication of our initial report in 2001 (AHRQ Publication No. 01-E012). DATA SOURCES: Ovid MEDLINE, reference lists of included studies, and non-indexed materials recommended by telemedicine experts. STUDY SELECTION: Included studies had to be relevant to at least one of the three study areas, address at least one key question, and contain reported results. We excluded articles that did not study the Medicare population (e.g., children and pregnant adults) or used a service that does not require face-to-face encounters (e.g., radiology or pathology diagnosis). DATA EXTRACTION: Our literature searches initially identified 4,083 citations. Using a dual-review process, 597 of these were judged to be potentially relevant to our study at the title/abstract level. Following a full-text review, 97 studies were identified that met our inclusion criteria and were subsequently included in the report's evidence tables. DATA SYNTHESIS: Store-and-forward services have been studied in many specialties, the most prominent being dermatology, wound care, and ophthalmology. The evidence for their efficacy is mixed, and in most areas, there are not corresponding studies on outcomes or improved access to care. Several limited studies showed the benefits of home-based telemedicine interventions in chronic diseases. These interventions appear to enhance communication with health care providers and provide closer monitoring of general health, but the studies of these techniques were conducted in settings that required additional resources and dedicated staff. Studies of office/hospital-based telemedicine suggest that telemedicine is most effective for verbal interactions, e.g., videoconferencing for diagnosis and treatment in specialties like neurology and psychiatry.
CONCLUSIONS: There are still significant gaps in the evidence base between where telemedicine is used and where its use is supported by high-quality evidence. Further well-designed and targeted research that provides high-quality data will provide a strong contribution to understanding how best to deploy technological resources in health care.

Entities:  

Mesh:

Year:  2006        PMID: 17900201      PMCID: PMC4781563     

Source DB:  PubMed          Journal:  Evid Rep Technol Assess (Full Rep)        ISSN: 1530-4396


  12 in total

1.  Impact on quality of life of a telemedicine system supporting head and neck cancer patients: a controlled trial during the postoperative period at home.

Authors:  Jaap L van den Brink; Peter W Moorman; Maarten F de Boer; Wim C J Hop; Jean F A Pruyn; Carel D A Verwoerd; Jan H van Bemmel
Journal:  J Am Med Inform Assoc       Date:  2007-01-09       Impact factor: 4.497

2.  Medicare payments, healthcare service use, and telemedicine implementation costs in a randomized trial comparing telemedicine case management with usual care in medically underserved participants with diabetes mellitus (IDEATel).

Authors:  Walter Palmas; Steven Shea; Justin Starren; Jeanne A Teresi; Michael L Ganz; Tanya M Burton; Chris L Pashos; Jan Blustein; Lesley Field; Philip C Morin; Roberto E Izquierdo; Stephanie Silver; Joseph P Eimicke; Rafael A Lantigua; Ruth S Weinstock
Journal:  J Am Med Inform Assoc       Date:  2010 Mar-Apr       Impact factor: 4.497

3.  In what circumstances is telemedicine appropriate in the developing world?

Authors:  Richard Wootton; Laurent Bonnardot
Journal:  JRSM Short Rep       Date:  2010-10-01

4.  A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study.

Authors:  Steven Shea; Ruth S Weinstock; Jeanne A Teresi; Walter Palmas; Justin Starren; James J Cimino; Albert M Lai; Lesley Field; Philip C Morin; Robin Goland; Roberto E Izquierdo; Susana Ebner; Stephanie Silver; Eva Petkova; Jian Kong; Joseph P Eimicke
Journal:  J Am Med Inform Assoc       Date:  2009-04-23       Impact factor: 4.497

5.  Technology use by rural and urban oldest old.

Authors:  James F Calvert; Jeffrey Kaye; Marjorie Leahy; Kari Hexem; Nichole Carlson
Journal:  Technol Health Care       Date:  2009       Impact factor: 1.285

6.  Telehealth and Medicare: payment policy, current use, and prospects for growth.

Authors:  Matlin Gilman; Jeff Stensland
Journal:  Medicare Medicaid Res Rev       Date:  2013-12-04

Review 7.  Health information technology to facilitate communication involving health care providers, caregivers, and pediatric patients: a scoping review.

Authors:  Stephen James Gentles; Cynthia Lokker; K Ann McKibbon
Journal:  J Med Internet Res       Date:  2010-06-18       Impact factor: 5.428

8.  Telerehabilitation: policy issues and research tools.

Authors:  Katherine D Seelman; Linda M Hartman
Journal:  Int J Telerehabil       Date:  2009-09-04

Review 9.  A Systematic Review of the Economic Evaluation of Telemedicine in Japan.

Authors:  Miki Akiyama; Byung-Kwang Yoo
Journal:  J Prev Med Public Health       Date:  2016-07

Review 10.  Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.

Authors:  Rebecca Ryan; Nancy Santesso; Dianne Lowe; Sophie Hill; Jeremy Grimshaw; Megan Prictor; Caroline Kaufman; Genevieve Cowie; Michael Taylor
Journal:  Cochrane Database Syst Rev       Date:  2014-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.